CXCL9 and cancer: In addition to the M1 versus M2 phenotyping, an alternative classification method using the relative expression levels of CXCL9 and SPP1 has been introduced to assess macrophage polarity, showing that the CXCL9:SPP1 ratio is associated with prognosis in cancer patients.82